Table 3.
Recognition rate (%) | Cross-validation rate (%) | |||||
---|---|---|---|---|---|---|
Malignant | Benign | Total | Malignant | Benign | Total | |
GA | 100.00 | 100.00 | 100.00 | 83.33 | 80.00 | 81.67 |
SNN | 88.37 | 90.38 | 89.38 | 72.22 | 90.00 | 81.11 |
QC | 67.44 | 94.23 | 80.84 | 72.22 | 100.00 | 86.11 |